Irace, Concetta <br/><br/>
Exenatide improves endothelial function assessed by flow mediated dilation technique in subjects with type 2 diabetes: results from an observational research.  [electronic resource] 

 -  Diabetes & vascular disease research  Jan 2013 
 - 72-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1752-8984 
<br/><br/><label>Standard No.: </label>10.1177/1479164112449562  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Blood Flow Velocity--physiology<br/>Brachial Artery--diagnostic imaging<br/>Diabetes Mellitus, Type 2--diagnostic imaging<br/>Drug Therapy, Combination<br/>Electrocardiography<br/>Endothelium, Vascular--drug effects<br/>Exenatide<br/>Female<br/>Glucagon-Like Peptide-1 Receptor<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Male<br/>Metformin--therapeutic use<br/>Middle Aged<br/>Peptides--therapeutic use<br/>Receptors, Glucagon--agonists<br/>Sulfonylurea Compounds--therapeutic use<br/>Ultrasonography, Doppler<br/>Vasodilation--drug effects<br/>Venoms--therapeutic use